Sarah Cavanaugh, SVP OF Corporate AFFAIRS & Administration at Celldex Therapeutics, Inc. (CLDX), sold 41,706 shares at $33.73 ($1.4M) on 2024-05-30, disclosed to the SEC on 2024-06-03.
Open-market sale of $1.4M CLDX by SVP OF Corporate AFFAIRS & Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.73 | 20,853 | $703K | 50.0% |
| 2 | $33.73 | 20,853 | $703K | 50.0% |
| Total | $33.73 avg | 41,706 | $1.4M | 100% |
| Filing → |
| CLDX | SELL | 2021-11-03 | $595K | — | Filing → |
| CLDX | BUY | 2020-06-11 | $5K | — | Filing → |